SureTrader Advertisement PRTC
Home > Boards > Free Zone > Big Board Trading - Technical > *SCALPSWINGSTRADDLE* ($$$)

Pharmacyclics pullback a buying opportunity, says Credit Suisse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
madrose1 Member Profile
Member Level 
Followed By 283
Posts 47,229
Boards Moderated 10
Alias Born 04/07/01
160x600 placeholder
Wall Street Looks To Economic Data For Clues On The Fed
Yellen hints at summer rate hike Memorial Day marks the unofficial beginning of summer, but baseball and barbecues may have to take a back...
Top Equities Stories Of The Day
Bank of America Relaunches Sale of Credit-Card Issuer MBNA
Culligan International Explores a Sale
Correction to Microsoft Smartphone Article on Wednesday
Facebook and Microsoft To Build Fiber Optic Cable Across Atlantic
Silicon Valley Driverless-Car Startup Raises Fresh Capital
ADRs End Mostly Lower; Alibaba, Baidu Trade Actively
Thermo Fisher Scientific to Buy FEI for $4.2 Billion
Correction to Valeant CEO Article on April 21
madrose1 Member Level  Monday, 03/25/13 08:37:55 AM
Re: None
Post # of 672515 
Pharmacyclics pullback a buying opportunity, says Credit Suisse
Credit Suisse would use the pullback in Pharmacyclics as a buying opportunity given the multi-billion dollar potential of ibrutinib. Shares are Outperform rated with a $90 price target

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist